Skip to main content
Industry News
Age not tied to negative outcomes with 2 IBD treatments

Age is not a factor in the hospitalization of patients with inflammatory bowel disease treated with vedolizumab and ustekinumab, but comorbidities are, according to a study published in Alimentary Pharmacology & Therapeutics. The risk is higher in patients with comorbidities due to a possible interaction with other medications and poorer response, researchers wrote.

Full Story: